drugset / Trial / NCT00603889

Development of a Skin Test for the Na-ASP-2 Hookworm Antigen

NCT00603889 ↗

Completed 12 enrolled Albert B. Sabin Vaccine Institute
NaSingle-groupOpen-labelDiagnostic

Summary

Na-ASP-2 is a protein expressed during the larval stage of the N. americanus hookworm life cycle. In a clinical study in previously hookworm-infected adults in Brazil, this protein induced urticarial reactions (rash) in a subset of volunteers. This study will evaluate solutions of varying concentrations of the protein in both a skin prick-puncture and intradermal test that will eventually be used to screen volunteers living in hookworm endemic areas who are being considered as potential participants in vaccine trials, to reduce the potential of inducing allergic reactions in those vaccinated with the Na-ASP-2 Hookworm Vaccine.

Timeline

Start
2008-03
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Na-ASP-2 Vaccine 1 ug/ml Other
Subject Na-ASP-2 Vaccine 10 ug/ml Other
Subject Na-ASP-2 Vaccine 100 ug/ml Other
Subject Na-ASP-2 Vaccine 1000 ug/ml Other